Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and blood pressure effects of sumatriptan alone and with telcagepant in migraine patients; completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Disorders

Drugs mentioned

• Sumatriptan (Sumatriptan)
• Telcagepant (telcagepant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Migraine Disorders | Phase 1 | Status: COMPLETED | Results posted: 2014-09-08